Benzinga's Top Downgrades
Analysts at Citigroup downgraded Actuant (NYSE: ATU) from “buy” to “neutral.” Actuant's shares closed at $25.81 yesterday. Actuant's trailing-twelve-month ROE is 14.43%.
Analysts at Goldman downgraded Xylem (NYSE: XYL) from “neutral” to “sell.” Xylem's shares closed at $24.29 yesterday. Xylem's PEG ratio is 2.33.
Analysts at Bernstein downgraded Weatherford International Ltd (NYSE: WFT) from “outperform” to “market perform.” Weatherford's shares closed at $12.24 yesterday. Weatherford's trailing-twelve-month profit margin is 2.53%.
JMP Securities downgraded Anthera Pharmaceuticals (NASDAQ: ANTH) from “outperform” to “market perform.” Anthera Pharmaceuticals' shares closed at $2.75 yesterday. Anthera Pharmaceuticals' trailing-twelve-month ROA is -92.62%.
Latest Ratings for ATU
|Nov 2015||SunTrust Robinson Humphrey||Initiates Coverage on||Buy|
|Oct 2015||JP Morgan||Upgrades||Underweight||Neutral|
|Sep 2015||Barclays||Initiates Coverage on||Equal-weight|
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.